Skip to content
This GLP
Updated September 2026Three supply lengths, no prescriber named

AHBARx review

Compounded semaglutide and tirzepatide in one, three and six-month supplies, with a physician founder named and no prescriber.

The verdict

AHBARx charges $249 for one month of compounded semaglutide. Tirzepatide is $349 for the same supply. Three and six-month supplies cost less per month. Every refill passes a follow-up consultation first.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
From
From $249/mo
Dose published
No
Prescription
Required
Compounded
Yes — not FDA-approved
Pharmacy
Not named
Availability
All 50 states
LegitScript
Claimed by provider

AHBARx is the online prescribing arm of AHBA, a wellness practice. It sells weight loss, longevity, anti-aging, sexual health and skin care treatments. Semaglutide and tirzepatide are its two GLP-1 products. B12, NAD+, glutathione and sermorelin make up most of the rest.

  1. Who writes the prescription, and what do they see?

    The FAQ states that licensed, board-certified clinicians review every plan. None of them is named. The about page names the founder, Dr. Nima Yazdanpanah, DO, a pain medicine physician. It does not say he reviews weight-loss requests. The review is described as a health intake followed by a consultation.

    The sequence is intake, consultation, then home delivery. Each monthly refill is reviewed in a follow-up consultation before it ships. The service is cash-pay and needs no insurance. The footer states service in all 50 states. An email sign-up offers 35 percent off a first eligible treatment.

  2. What happens when the dose goes up?

    No milligram appears on either product page. The pages do not say whether the price changes as the dose rises. Dosing guidance is assigned to the provider, with injection technique and site rotation. The monthly refill consultation is the stated checkpoint for a change.

  3. What the price includes

    Semaglutide is $249 for one month, $649 for three and $1,199 for six. Tirzepatide is $349, $949 and $1,799 on the same ladder. Each card prints its saving: $98 on three months, $295 on six. No card is preselected. The six-month card is marked most popular. It is charged every six months and ships every three.

  4. What it claims, and what it cites

    Both products are compounded. The FAQ says they come from U.S.-based, FDA-registered compounding pharmacies. None is named. Each product page states that compounded medications are not reviewed or approved by the FDA. No formulation detail is given beyond a subcutaneous injection.

Where it holds up, and where it does not

  • Strength: One-month rate printed beside each longer supply
  • Strength: Savings on longer supplies printed in dollars
  • Strength: Every refill reviewed in a follow-up consultation
  • Strength: FDA status of compounding stated on both pages
  • Limitation: No prescribing clinician is named
  • Limitation: No milligram appears beside any price
  • Limitation: The compounding pharmacy is not named
  • Limitation: Price at higher doses is not addressed

What the evidence says about this kind of treatment

The assessment above is about AHBARx. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A buyer who wants to start on one month and choose a longer supply later.
Wrong for
A buyer who needs the dose and the pharmacy named before paying.

How AHBARx compares

SellerWho it suitsGo
DreamHug MedicalA reader signing for the longest term who needs a broad list of served statesSee DreamHug Medical
LibertyA reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing.See Liberty
MondaeBuyers who want a low published compounded rate and few other detailsSee Mondae
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: SnagRxStrut HealthSynergy RxTrimi HealthActinAgelessRx

Sponsored alternative

Bodybuilding Health+

A reader unwilling to prepay a year before seeing how the drug goes

Check Bodybuilding Health+ availability →

Frequently asked

Is $249 an introductory price?
No. It is the one-month supply rate, delivered monthly. Lower monthly rates require buying three or six months at once.
Who reviews the request?
The FAQ says licensed, board-certified clinicians. No prescriber is named anywhere on the site.
Does the six-month supply ship at once?
No. It is charged every six months. Medication is delivered every three months.
Is AHBARx legit?
AHBARx is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
Is AHBARx expensive compared with other GLP-1 telehealth sellers?
AHBARx publishes a starting figure of $249/mo. Across the 273 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $399 with a median of $179, which puts AHBARx above the median. The other 19 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Glenn TorresStandards editor · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from AHBARx’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.